Scientists have taken a significant step forward in their quest that humans regenerate or re-grow lost limbs and other body parts.
A team of scientists at the MDI Biological Laboratory in Bar Harbor, Maine is studying the genetics of organisms such as salamanders that can re-grow lost body parts to find out how regenerative mechanisms might be activated in humans.
It's always been a mystery why many lower organisms retain the miraculous ability to regenerate form and function of almost any tissue after injury. Humans share many of our genes with these organisms, but our capacity for regeneration is limited.
In a paper published in the journal PLOS ONE, MDI scientists Benjamin L. King, Ph.D., and Voot P. Yin, Ph.D., identified these common genetic regulators in three regenerative species: the zebrafish, a common aquarium fish originally from India; the axolotl, a salamander native to the lakes of Mexico; and the bichir, a ray-finned fish from Africa.
The discovery of genetic mechanisms common to all three of these species, which diverged on the evolutionary tree about 420 million years ago, suggests these mechanisms aren't specific to individual species, but have been conserved by nature through evolution.
"I remember that day very well -- it was a fantastic feeling," said King of the discovery.
"We didn't expect the patterns of genetic expression to be vastly different in the three species, but it was amazing to see that they were consistently the same."
The discovery of the common genetic regulators is expected to serve as a platform to inform new hypotheses about the genetic mechanisms underlying limb regeneration. The discovery represents a major advance in understanding why many tissues in humans, including limb tissue, regenerate poorly -- and in being able to possibly manipulate those mechanisms with drug therapies.
"Limb regeneration in humans may sound like science fiction, but it's within the realm of possibility," said Yin.
"The fact that we've identified a genetic signature for limb regeneration in three different species with three different types of appendages suggests that nature has created a common genetic instruction manual governing regeneration that may be shared by all forms of animal life, including humans."
In particular, the scientists studied the formation of a mass of cells called a blastema that serves as a reservoir for regenerating tissues. The formation of a blastema is the critical first step in the regeneration process.
Using sophisticated genetic sequencing technology, King and Yin identified a common set of genes that are controlled by a shared network of genetic regulators known as microRNAs.
"Scientists here are studying an evolutionarily diverse range of animals to gain insight into the genetic mechanisms underlying the repair and regeneration of complex tissues and why these processes are poorly active in humans," said Kevin Strange, Ph.D., the laboratory's president.
"The value of our approach is confirmed by this remarkable study, which for the first time reveals a genetic network governing limb regeneration that is common across three evolutionarily distinct animal species."
The study also has implications for wound healing, which involves similar genetic mechanisms. With a greater understanding of these mechanisms, treatments could potentially be developed to speed wound healing, thus reducing pain, decreasing risk of infection and getting patients back on their feet more quickly.
Another potential application is development of more sophisticated prosthetic devices. When a limb is amputated the nerves at the site of amputation can be damaged. The repair and regeneration of these nerves could potentially enable the development of more sophisticated prostheses that could interface with these nerves, allowing for greater control.
While speedier wound-healing and improved prostheses may be on the nearer-term horizon, the ability to regrow limbs is a long way off. How long?
"It depends on the pace of discovery, which is heavily dependent on funding," Yin said. He predicted the timeline could be hastened if enough research funding were available.
"Unfortunately," he added, "we are in a period of greatly diminished funding for scientific research."